Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.31 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.31 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13502522 | 0.80 | ALDH1A1 (0.38) | TP53SLC7A5ALDH1A1MAPTPTGS1 | |
| SCHEMBL5568674 | 0.78 | ALDH1A1 (0.36) | TP53SLC7A5ALDH1A1MAPTPTGS1 | |
| SCHEMBL10953833 | 0.78 | TP53 (0.36) | TP53SLC7A5ALDH1A1MAPTPTGS1 | |
| SCHEMBL7877645 | 0.77 | TP53 (0.40) | TP53SLC7A5ALDH1A1MAPTPTGS1 | |
| SCHEMBL8734218 | 0.77 | TP53 (0.40) | TP53SLC7A5ALDH1A1MAPTPTGS1 | |
| SCHEMBL17777229 | 0.74 | TP53 (0.38) | TP53SLC7A5ALDH1A1MAPTPTGS1 | |
| SCHEMBL18211564 | 0.74 | TP53 (0.45) | TP53SLC7A5ALDH1A1MAPTPTGS1 | |
| SCHEMBL22355731 | 0.74 | TP53 (0.38) | TP53SLC7A5ALDH1A1MAPTPTGS1 | |
| SCHEMBL17201497 | 0.74 | TP53 (0.45) | TP53SLC7A5ALDH1A1MAPTPTGS1 | |
| SCHEMBL13395692 | 0.74 | TP53 (0.38) | TP53SLC7A5TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111205397-B | Ionic liquid grafted cellulose nanocrystal and preparation method thereof | 青岛科技大学 | 2022-08-23 | — | — | CN | claimed |
| CN-111205397-A | Ionic liquid grafted cellulose nanocrystal and preparation method thereof | 青岛科技大学 | 2020-05-29 | — | — | CN | claimed |
| EP-0108645-A2 | Novel ailanthone derivative | SUNTORY LIMITED (JP) | 1984-05-16 | — | — | EP | claimed |
| EP-4711434-A1 | REFRIGERANT CYCLE APPARATUS | Daikin Industries, Ltd. (JP) | 2026-03-18 | — | — | EP | disclosed |
| EP-4234293-B1 | REFRIGERATION CYCLE DEVICE FOR VEHICLE | DAIKIN IND LTD (JP) | 2025-12-24 | — | — | EP | disclosed |
| US-12441922-B2 | Refrigerant-containing composition, use of same, refrigerator having same, operation method for said refrigerator, and refrigeration cycle device equipped with same | DAIKIN INDUSTRIES, LTD. (JP) | 2025-10-14 | — | — | US | disclosed |
| US-20250115796-A1 | REFRIGERATION CYCLE APPARATUS | DAIKIN INDUSTRIES, LTD. (JP) | 2025-04-10 | — | — | US | disclosed |
| EP-4083174-B1 | REFRIGERATION CYCLE DEVICE, REFRIGERATION MACHINE OIL AND REFRIGERANT LEAKAGE PREVENTION AGENT | DAIKIN IND LTD (JP) | 2025-01-22 | — | — | EP | disclosed |
| EP-3825383-B1 | REFRIGERATION CYCLE DEVICE FOR VEHICLE | DAIKIN IND LTD (JP) | 2024-11-06 | — | — | EP | disclosed |
| EP-3825379-B1 | REFRIGERANT CYCLE DEVICE | DAIKIN IND LTD (JP) | 2024-10-30 | — | — | EP | disclosed |
| US-20240218226-A1 | REFRIGERATION CYCLE DEVICE FOR VEHICLE | DAIKIN INDUSTRIES, LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20130207024-A1 | REFRIGERATING MACHINE OIL AND WORKING FLUID COMPOSITION FOR REFRIGERATING MACHINES | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2013-08-15 | — | — | US | disclosed |
| EP-2610329-A1 | REFRIGERATING MACHINE OIL AND WORKING FLUID COMPOSITION FOR REFRIGERATING MACHINES | JX Nippon Oil & Energy Corporation (JP) | 2013-07-03 | — | — | EP | disclosed |
| CN-103097501-A | Refrigerator oil and working fluid composition for refrigerator | JX NIPPON OIL & ENERGY CORP | 2013-05-08 | — | — | CN | disclosed |
| US-8211932-B2 | Organic compounds and their uses | NOVARTIS AG (CH) | 2012-07-03 | — | — | US | disclosed |
| EP-2134346-B1 | INHIBITORS OF JANUS KINASES AND/OR 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1 | MERCK SHARP & DOHME (US) | 2011-09-21 | — | — | EP | disclosed |
| US-20100331243-A1 | ORGANIC COMPOUNDS AND THEIR USES | NOVARTIS AG (CH) | 2010-12-30 | — | — | US | disclosed |
| US-7825152-B2 | serine protease inhibitors, for the treatment of hepatitis c virus infections | NOVARTIS AG (CH) | 2010-11-02 | — | — | US | disclosed |
| US-20100204159-A1 | ORGANIC COMPOUNDS AND THEIR USES | NOVARTIS AG (CH) | 2010-08-12 | — | — | US | disclosed |
| US-20070286842-A1 | Organic Compounds and Their Uses | NOVARTIS AG (CH) | 2007-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331243-A1 | ORGANIC COMPOUNDS AND THEIR USES | OAT, OTC, AOX1 | TP53 784/4885SLC7A5 945/4885ALDH1A1 135/4885 |
| US-20070286842-A1 | Organic Compounds and Their Uses | OAT, OTC, AOX1 | TP53 784/4885SLC7A5 945/4885ALDH1A1 135/4885 |
| US-20100204159-A1 | ORGANIC COMPOUNDS AND THEIR USES | OAT, OTC, AOX1 | TP53 784/4885SLC7A5 945/4885ALDH1A1 135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.